OWD
MBII

Osborn Williams & Donohoe’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Osborn Williams & Donohoe’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,500
Closed -$4K – 709
2019
Q1 		$4K Buy
+2,500
New +$3.81K ﹤0.01% 710

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

Osborn Williams & Donohoe's MBII Position: Q2 2019 in Review

Osborn Williams & Donohoe sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2019, closing a stake of 2,500 shares — an estimated $4K sold.

Osborn Williams & Donohoe first reported a position in MBII in Q1 2019 and held it in 1 quarter. The position peaked at $4K in Q1 2019. 49 funds tracked by Wall St. Rank hold MBII as of Q2 2019.

  • Osborn Williams & Donohoe reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2019 after selling out during the quarter.
  • Osborn Williams & Donohoe sold 2,500 Marrone Bio Innovations, Inc. shares in Q2 2019, an estimated $4K.
  • Osborn Williams & Donohoe first reported a position in Marrone Bio Innovations, Inc. in Q1 2019 and held it in 1 quarter.
  • Osborn Williams & Donohoe's Marrone Bio Innovations, Inc. position peaked at $4K in Q1 2019.
  • 49 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2019.

Based on Osborn Williams & Donohoe's 13F filing for Q2 2019, filed 26 Jul 2019.